"/> Novus Biologicals™ Antigène protéique recombinant… | B-LABO France

Novus Biologicals™ Antigène protéique recombinant Annexin A13

Réf. : BL-RE-050017Réf. fabricant : 18288938 0.1mL
242,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
312
Espèces
Human
Méthode de purification
Chromatography
Pureté
>80%
Concentration
0.5mg/mL
Marque
Novus Biologicals

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human ANXA13. The Annexin A13 Recombinant Protein Antigen is derived from E. coli. The Annexin A13 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

This is a blocking peptide for NBP1-90157. This is a human recombinant protein expressed in E. coli with a N-terminal His-ABP tag and purified with IMAC chromatography.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-050017
Réf. fabricant18288938
Gene ID (Entrez)312
EspècesHuman
Méthode de purificationChromatography
Pureté>80%
Concentration0.5mg/mL
Contenu et stockageStore at -20°C. Avoid freeze-thaw cycles.
FormulePBS and 1M Urea, pH 7.4.
À utiliser avec (application)Blocking/Neutralizing, Control
Symbole de gène(s)ANXA13
Type d’étiquetteUnlabeled
Poids moléculaire26kDa
Type de produitAnnexin A13
Quantité0.1mL
État réglementaireRUO
SourceE.Coli
Réactivité spécifiqueThis recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP1-90157. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
ImmunogèneCTRTNKEIIAIKEAYQRLFDRSLESDVKGDTSGNLKKILVSLLQANRNEGDDVDKDLAGQDAKDLYDAGEGRWGTDEL
Une question, une configuration particulière ?
Contactez-nous pour un devis.